The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
Museums take this educational role seriously, and many institutions understand the need to sustain and broaden their appeal. “They used to be these big ivory towers of knowledge and history and thought and art,” said Hilary Knight, director of Change& in London and former director of digital at Tate. “Museums themselves are changing their role to be centers for discussion and encounter and to be much more participatory.”
'Ghost ships' are vessels that disappear from public tracking systems, their location manipulated or their digital record misleading. An estimated 65% of outbound tankers crossing the Strait of Hormuz operate in dark mode, reducing visibility and increasing supply chain uncertainty. Misinformation in vessel tracking can cause manufacturing delays, compliance risks and financial losses. Layered verification processes, combining AIS data with other sources and escalation triggers for handling uncertain shipments, can help mitigate risk.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
There was not any vote taken about mixing and matching,” said N.C. State/public health scientist Dr. Julie Swann. The official guidance is to get the same vaccine for your COVID vaccine booster dose as you did previously.
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
Step into one of Maryum Al-Hammami’s Southern California toy stores called The Game Chest, and you'll find the experience is as important as a purchase.
The supply chain disruption is shorthand for problems from factory closures to workers who are not working anymore.
New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach would substantially contrast with the current FDA approaches for monitoring drug safety, which suffers major drawbacks (e.g., they are based on voluntary reports that can result in inaccurate or untimely decisions).
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine